Watch and see why a diagnosis of ATTR-CM doesn't have to define what's possible.
Proven results
with Attruby
Ken, taking Attruby for ATTR-CM,
and his care partner, Mary.
Attruby delivered rapid and sustained results in wild-type
and
hereditary
ATTR-cardiac amyloidosis (ATTR-CM)
(placebo
Impact on survival and hospitalizations due to heart issues was observed as early as 3 months.
When comparing results in people treated with and without Attruby at 30 months,
people taking Attruby experienced:
42% more likely to live longer and have fewer repeat hospitalizations due to heart issues
These results come from a follow-up study.
Less likely to be hospitalized due to heart issues (an average of 0.3 vs 0.6 visits per year)
A better health-related quality of life*†
These results come from a follow-up study.
Impact on health-related quality of life was first observed after 3 months.†
When comparing health-related quality of life measures in people treated with and without Attruby at 30 months, people treated with Attruby reported better results:
-
Symptoms
Reduced shortness of breath and fatigue,as well as less swelling in the legs, ankles, and feet.
-
Physical abilities
Ability to walk 1 block on level ground and climbing up a short flight of stairs without stopping.‡
-
Social engagement
People were able to experience better overall enjoyment of life, such as visiting with family or friends.§
*The treatment effect of Attruby on health
status was assessed using the Kansas City Cardiomyopathy Questionnaire-Overall Summary
(KCCQ-OS)
score composed of the physical limitation, symptom, social limitation, quality of life, and
self-efficacy
domains, respectively.
†At the end of the 30-month study of adults with ATTR-CM, on average, people taking and not taking Attruby experienced a decline in their KCCQ-OS, a measure of health-related quality of life.
‡Other physical improvements included ability to do household chores and showering or bathing independently.
§This also included better engagement with their hobbies or enjoying intimate relationships.